Short Interest in Agape ATP Corporation (NASDAQ:ATPC) Drops By 94.0%

Agape ATP Corporation (NASDAQ:ATPC) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totaling 18,792 shares, a decrease of 94.0% from the May 31st total of 314,161 shares. Based on an average daily volume of 804,194 shares, the short-interest ratio is presently 0.0 days. Currently, 1.9% of the company’s stock are sold short.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Wall Street Zen downgraded shares of Agape ATP from a “hold” rating to a “sell” rating in a research note on Sunday, June 21st. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a report on Friday, May 22nd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Agape ATP Stock Performance

ATPC stock opened at $2.98 on Friday. Agape ATP has a one year low of $1.72 and a one year high of $75.25. The firm has a market cap of $2.98 million, a price-to-earnings ratio of -2.24 and a beta of 0.08. The firm has a 50-day simple moving average of $2.89 and a two-hundred day simple moving average of $4.28.

Agape ATP (NASDAQ:ATPC) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. Agape ATP had a negative return on equity of 8.43% and a negative net margin of 125.89%.The firm had revenue of $0.27 million during the quarter.

Institutional Investors Weigh In On Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC grew its stake in shares of Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 65,130 shares of the company’s stock after acquiring an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. 0.01% of the stock is owned by institutional investors.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.